HSBC Holdings’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,861
Closed -$358K 3176
2024
Q4
$358K Buy
3,861
+1,170
+43% +$113K ﹤0.01% 2384
2024
Q3
$249K Buy
+2,691
New +$233K ﹤0.01% 2475
2023
Q1
Sell
-4,569
Closed -$208K 2874
2022
Q4
$208K Buy
+4,569
New +$214K ﹤0.01% 2751
2022
Q3
Sell
-5,128
Closed -$237K 3113
2022
Q2
$237K Sell
5,128
-513
-9% -$22.9K ﹤0.01% 2790
2022
Q1
$263K Buy
+5,641
New +$252K ﹤0.01% 2837
2021
Q2
Sell
-6,528
Closed -$318K 3012
2021
Q1
$318K Buy
+6,528
New +$306K ﹤0.01% 2251
2019
Q4
Sell
-17,102
Closed -$585K 3129
2019
Q3
$585K Buy
+17,102
New +$546K ﹤0.01% 2238
2017
Q4
Sell
-32,074
Closed -$1.2M 2245
2017
Q3
$1.2M Buy
+32,074
New +$1.09M ﹤0.01% 1437
2015
Q3
Sell
-15,000
Closed -$182K 2068
2015
Q2
$182K Buy
+15,000
New +$148K ﹤0.01% 1852

Other funds holding LMAT

HSBC Holdings's LMAT Position: Q1 2025 in Review

HSBC Holdings sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 3,861 shares — an estimated $358K sold.

HSBC Holdings first reported a position in LMAT in Q2 2015 and held it in 9 quarters. The position peaked at $1.2M in Q3 2017. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • HSBC Holdings reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • HSBC Holdings sold 3,861 LeMaitre Vascular shares in Q1 2025, an estimated $358K.
  • HSBC Holdings first reported a position in LeMaitre Vascular in Q2 2015 and held it in 9 quarters.
  • HSBC Holdings's LeMaitre Vascular position peaked at $1.2M in Q3 2017.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on HSBC Holdings's 13F filing for Q1 2025, filed 14 May 2025.